Patients started a GLP-1 or a DPP-4 inhibitor for reasons the data cannot fully control for
Several studies are underway to test adjunctive therapies in type 1 diabetes and may help move the needle towards approvals
A patient with a muscle strain may benefit from BPC-157, but tissue healing still requires time, protein, sleep, and a structured return to activity
Of note also Aspartame, Acesulfame K, Glycyrrhizin and Saccharin bind the sweet receptor heterodimer Tas1R2/3 and they have shown to stimulate GLP-1 secretion in the human duodenal adenocarcinoma-derived HuTu-80 cell line (245, 246)
Since we know the results of this allowance we should just make a certain % sugar content illegal for retail regardless
Retrieved from Genetic Lifehacks